article thumbnail

Biofourmis announces major agreements with top pharmaceutical companies

Digital Health Global

Biofourmis , a global digital health and clinical trial solutions leader, announces four key partnerships with top pharmaceutical firms. Beyond digital biomarker and endpoint expertise, pharmaceutical partners are leveraging Biofourmis to streamline study timelines through its Digital Clinical Trials solution.

article thumbnail

The Whyse®, in Collaboration with Pharmaceutical Executive®, Launches Virtual Digital Leadership Event: word to the whyse

MedTech Boston

The Whyse®, a digital healthcare marketing agency with matchless access to unlimited physician-level data, in collaboration with Pharmaceutical Executive®, a multimedia platform for.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Committee to Restore Nymox Shareholder Value Sends Letter to Nymox Pharmaceutical Shareholders and Issues Proxy Materials for Upcoming Special Meeting

Digital Health Global

Believes Nymox Management and Board Must Be Held Accountable for Prolonged Underperformance and Egregious Governance Practices Urges Shareholders to Vote on the WHITE Proxy Card to Install New Leadership and a New Board at Upcoming Special Meeting CARSON CITY, Nev. & The Committee to Restore Nymox Shareholder Value, Inc.

article thumbnail

EVERSANA Expands Global Commercialisation Capabilities and Strengthens Agency Network with Healthware Group Acquisition

Digital Health Global

The acquisition immediately expands EVERSANA’s European operations and worldwide capabilities to help pharmaceutical, medical device, and emerging biotech companies globally launch products, expand market access, or solve unique geographic and market-specific challenges.

article thumbnail

Redi Health Lands $14 Million Investment to Continue Improving Patient Health Outcomes by Connecting Pharma, Providers, and Patients in One Platform

Healthcare IT Today

This results in a non-adherence rate of approximately 70%, resulting in an estimated annual revenue loss of $637 billion for the pharmaceutical industry. This is the first pharmaceutical platform that enables the free flow of real-time information with Redi Health’s unique compliance architecture.

article thumbnail

Aptar Appoints Julie Xing to its Board of Directors

Digital Health Global

With over 20 years of experience in pharmaceutical, medtech, digital health, biotech and diagnosis, Julie’s leadership approach focuses on inspiring teams to deliver sustainable growth in challenging markets and healthcare environments. Mundipharma is a global pharmaceutical leader. Tanda, Aptar President and CEO.

article thumbnail

The Evolution of a Patient Ambassador – Learning from Stacy Hurt

Health Populi

Tallying up the years between her working in physician practice management and the pharmaceutical sector, as well as time spent in health advocacy, “I’ve been 25 years in health care,” Stacy calculated. Following the program, the company asked her to give a talk at their global leadership summit in January 2022.